| Safety of PCI-32765 in Chronic Lymphocytic Leukemia (NCT01105247) | Pharmacyclics LLC. | 2010-05-01 |
| Efficacy of a Multi-strain Probiotic in the Treatment of Irritable Bowel Syndrome (IBS) (NCT01176227) | The Canadian College of Naturopathic Medicine | 2010-05-01 |
| Determine Central 5-HT1B Receptor Occupancy of ZOMIG® Rapimelt (Zolmitriptan) in Healthy Male Volunteers (NCT01085123) | AstraZeneca | 2010-05-01 |
| A Study of the Safety and Pharmacokinetics of Single Ascending Oral Doses of INX-08189 in Healthy Subjects (NCT01159808) | Bristol-Myers Squibb | 2010-05-01 |
| A Single-Dose, Pharmacokinetic/Pharmacodynamic (PK/PD), & Safety Study of BIIB017 in Participants With Renal Impairment & Healthy Volunteers (NCT01119781) | Biogen | 2010-05-01 |
| Evaluation of Ridge Dimensional Changes After Immediate Implantation and Efficacy of This Procedure (NCT01399775) | Mashhad University of Medical Sciences | 2010-05-01 |
| Bioequivalence of Two Lispro Formulations (NCT01133392) | Eli Lilly and Company | 2010-05-01 |
| A Clinical Trial to Compare and Evaluate the Pharmacokinetic Characteristics and the Safety of Fimasartan in Hepatic Impairment Patients and Healthy Volunteers (NCT01146938) | Boryung Pharmaceutical Co., Ltd | 2010-05-01 |
| Safety and Immunogenicity of a Group B Streptococcus Vaccine in Healthy Women (NCT01150123) | Novartis Vaccines | 2010-05-01 |
| Chemoradiation Plus Weekly c225 Against Locoregionally Advanced Nasopharyngeal Carcinoma (NPC) (NCT01712919) | Jiangsu Cancer Institute & Hospital | 2010-05-01 |
| Belinostat and Bortezomib in Treating Patients With Relapsed or Refractory Acute Leukemia or Myelodysplastic Syndrome (NCT01075425) | Virginia Commonwealth University | 2010-05-01 |
| Safety and Immunogenicity of CVD 1902 Oral Attenuated Vaccine to Prevent S. Paratyphi A Infection (NCT01129453) | University of Maryland, Baltimore | 2010-05-01 |
| Single-dose, Pharmacokinetics of AMG 853 in Healthy Adult Subjects (NCT01124279) | Amgen | 2010-05-01 |
| Treatment of Knee Osteoarthritis With Autologous Mesenchymal Stem Cells (NCT01183728) | Red de Terapia Celular | 2010-05-01 |
| Sunitinib Plus Temsirolimus in Patients With Renal Cell Cancer (RCC) (NCT01122615) | M.D. Anderson Cancer Center | 2010-05-01 |
| Safety and Efficacy Study of WRSS1, a Shigella Sonnei Vaccine Candidate (NCT01080716) | U.S. Army Medical Research and Development Command | 2010-05-01 |
| A Study to Explore Plasma Levels of CONCERTA, Ritalin-SR and Novo-Methylphenidate ER-C in Healthy Volunteers (NCT01118702) | Janssen-Ortho Inc., Canada | 2010-05-01 |
| Safety and Efficacy Study of a Non-antibiotic Treatment for the Eradication of Helicobacter Pylori (NCT01109381) | Synergy Pharmaceuticals Pte. Ltd. | 2010-05-01 |
| Pharmacokinetic and Comparative Bioavailability Study of Testosterone Absorption After Administration of Testosterone Gel 1.62% to the Upper Arms/Shoulders Using an Application Site Rotation or a Combination of Application Sites in Hypogonadal Males (NCT01133548) | AbbVie | 2010-05-01 |
| Pilot Study for Palliation of Pain in Bone Metastases by MR-HIFU (NCT01117246) | Philips Healthcare | 2010-05-01 |
| Intravenous (IV) Decitabine and Oral Bexarotene for Acute Myelogenous Leukemia (AML) (NCT01001143) | Washington University School of Medicine | 2010-05-01 |
| Vorinostat and Lenalidomide in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma or Non-Hodgkin Lymphoma (NCT01116154) | City of Hope Medical Center | 2010-05-01 |
| A Pilot Study to Evaluate the Role of High-dose Ranibizumab (2.0mg) in the Management of AMD in Patients With Persistent/Recurrent Macular Fluid Less Than 30 Days Following Treatment With Intravitreal Anti-VEGF Therapy (the LAST Study) (NCT01115556) | Vitreous -Retina- Macula Consultants of New York | 2010-05-01 |
| Intracavernous Bone Marrow Stem-cell Injection for Post Prostatectomy Erectile Dysfunction (NCT01089387) | Institut National de la Santé Et de la Recherche Médicale, France | 2010-05-01 |
| A Study to Evaluate the Effect of Oral Mirabegron on the Heart in Healthy Males and Females (NCT01199523) | Astellas Pharma Inc | 2010-05-01 |
| Safety Study of Single Administration Post-Exposure Prophylaxis Treatment for Ebola Virus (NCT01353027) | Sarepta Therapeutics, Inc. | 2010-05-01 |
| A Study of the Safety and Efficacy of CNTO 888 in Combination With SoC (Standard of Care) Chemotherapy in Patients With Solid Tumors (NCT01204996) | Centocor, Inc. | 2010-05-01 |
| Safety and Efficacy Study of Dose-escalated Hypofractionated Radiotherapy For Prostate Cancer (NCT01146340) | Sunnybrook Health Sciences Centre | 2010-05-01 |
| A Dose-Escalation Study Designed to Evaluate the Tolerability, Safety, Pharmacokinetics (PK), and Efficacy of Chronic Topical Ocular Application of INO-8875 in Adults With Ocular Hypertension or Primary Open-Angle Glaucoma (NCT01123785) | Inotek Pharmaceuticals Corporation | 2010-05-01 |
| Drug Interaction Between Colchicine and Calcineurin Inhibitors in Renal Graft Recipients (NCT01160276) | Assistance Publique - Hôpitaux de Paris | 2010-05-01 |
| Safety and Tolerability of Cidofovir Gel Applied on Cervix Squamous Lesions (NCT00989443) | Mithra Pharmaceuticals | 2010-05-01 |
| A Pharmacokinetic Study to Compare Sustained Release and Standard Paracetamol Formulations. (NCT01551797) | GlaxoSmithKline | 2010-05-01 |
| IV Plerixafor With Mitoxantrone Etoposide and Cytarabine for Acute Myeloid Leukemia (AML) (NCT01027923) | Washington University School of Medicine | 2010-05-01 |
| Erlotinib Hydrochloride and Isotretinoin in Treating Patients With Recurrent Malignant Glioma (NCT01103375) | Wake Forest University Health Sciences | 2010-05-01 |
| Double-Blind, Randomized, Single Dose Escalation Safety Study of Intraarticular Bone Morphogenic Protein (38A BMP-7) in Subjects With Osteoarthritis (OA) of the Knee (NCT01133613) | Stryker Biotech | 2010-05-01 |
| Study of CS-1008 in Combination With FOLFIRI in Patients Who Have Failed Other Treatments (NCT01124630) | Daiichi Sankyo | 2010-05-01 |
| Treatment Resistant Geriatric Depression in Primary Care (NCT01392287) | Mclean Hospital | 2010-05-01 |
| BMAC Enhanced Coronary Artery Bypass Grafting (CABG) (NCT01061580) | Harvest Technologies | 2010-05-01 |
| Raltegravir in Patients With End Stage Liver Disease and in Transplant Recipients (NCT01022476) | ANRS, Emerging Infectious Diseases | 2010-05-01 |
| A Feasibility Study Designed to Assess the Efficacy of the ActiLady Device in Adult Female Subjects With Dysmenorrhea (NCT00855829) | Hadassah Medical Organization | 2010-05-01 |
| A Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of JNJ-40411813 in Male and Female Elderly Patients (NCT01932333) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2010-05-01 |
| The Role of Endothelin in the Supine Hypertension of Autonomic Failure (NCT01119417) | Vanderbilt University | 2010-05-01 |
| Evaluation of a Tongue Operated Assistive Technology for Individuals With Severe Paralysis (NCT01124292) | Georgia Institute of Technology | 2010-05-01 |
| A Blinded, Four-Way Crossover in Healthy Subjects to Assess EEG After Administration of Ketamine, Placebo and AZD6765 (NCT01130909) | AstraZeneca | 2010-05-01 |
| Multiple Ascending Doses Study of CG400549 (NCT01848470) | CrystalGenomics, Inc. | 2010-05-01 |
| Dose Escalation, Safety and Pharmacokinetic Study of AVE8062 Combined With Docetaxel and Cisplatin in Patients With Solid Tumors (NCT01095302) | Sanofi | 2010-05-01 |
| A Study of IMC-RON8 in Advanced Solid Tumors (NCT01119456) | Eli Lilly and Company | 2010-05-01 |
| To Investigate Safety, Tolerability, and Pharmacokinetics of Treatment With BI 660848 Rising Single Doses (From 2 mg to 600 mg) Administered as Oral Drinking Solution (Powder in Bottle). (NCT01145014) | Boehringer Ingelheim | 2010-05-01 |
| Drug Interaction Study Between Rifabutin And Lersivirine (UK-453,061) (NCT00925535) | Pfizer | 2010-05-01 |
| Open Label Study, Assessing the Effect of Diltiazem or Ketoconazole on the Pharmacokinetics of AZD9742 in Healthy Volunteers (NCT01124760) | AstraZeneca | 2010-05-01 |
| Nitric Oxide Mediated Vasodilatory Response to Hawthorn Standardized Extract (NCT01331486) | University of North Carolina, Chapel Hill | 2010-05-01 |
| A Study in Healthy Subjects to Determine the Effects When Alcohol is Administered With Perampanel (NCT01531920) | Eisai Limited | 2010-05-01 |
| Study to Investigate Single Ascending Oral Doses of AZD5213 in Healthy Male and Non Fertile Female Subjects (NCT01121302) | AstraZeneca | 2010-05-01 |
| RO4929097, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Malignant Glioma (NCT01119599) | National Cancer Institute (NCI) | 2010-05-01 |
| Study of a DNA Immunotherapy to Treat Melanoma (NCT01138410) | Scancell Ltd | 2010-05-01 |
| Study of PVS-10200 for the Treatment of Restenosis in Patients With Peripheral Artery Disease (TRIUMPH) (NCT01099215) | Shire | 2010-04-30 |
| A Pilot Study of EZN-2968, an Antisense Oligonucleotide Inhibitor of HIF-1alpha, in Adults With Advanced Solid Tumors With Liver Metastases (NCT01120288) | National Cancer Institute (NCI) | 2010-04-29 |
| Granulocyte Colony-stimulating Factor (G-CSF) Plus or Minus AMD3100 for Engraftment Post Allogeneic Transplant (NCT01026987) | Washington University School of Medicine | 2010-04-29 |
| GSK573719 IV Enabling Study (NCT01110018) | GlaxoSmithKline | 2010-04-28 |
| Safety, Pharmacodynamics and Pharmacokinetics of GSK2136525 Repeat Dose in Rheumatoid Arthritis (NCT01077531) | GlaxoSmithKline | 2010-04-28 |
| Trial Of Cisplatin And KML-001 in Platinum Responsive Malignancies (NCT01110226) | University of Maryland, Baltimore | 2010-04-27 |
| Combination Gene Transfer and Chemotherapy (NCT01119664) | Abramson Cancer Center at Penn Medicine | 2010-04-27 |
| Nab-paclitaxel, Gemcitabine, and Bevacizumab in Advanced Malignancies (NCT01113476) | M.D. Anderson Cancer Center | 2010-04-27 |
| Bortezomib and Romidepsin in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (NCT00963274) | Virginia Commonwealth University | 2010-04-26 |
| Donor Peripheral Blood Stem Cell Transplant and Pretargeted Radioimmunotherapy in Treating Patients With High-Risk Advanced Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndrome (NCT00988715) | Fred Hutchinson Cancer Center | 2010-04-21 |
| Gene Therapy for Wiskott-Aldrich Syndrome (NCT01515462) | Fondazione Telethon | 2010-04-20 |
| A Multiple Ascending Dose Study of ETC-1002 in Subjects With Mild Dyslipidemia (NCT01105598) | Esperion Therapeutics, Inc. | 2010-04-20 |
| Fludarabine, Bendamustine, and Rituximab (FBR) for Relapsed Chronic Lymphocytic Leukemia (CLL) (NCT01096992) | M.D. Anderson Cancer Center | 2010-04-19 |
| Single Dose Escalation Study to Investigate the Pharmacokinetics as Well as Safety and Tolerability of a Concomitant Administration of Nifedipne GITS and Candesartan Tablets Under Fasting Conditions in Healthy Male Subjects in an Open Label, Non-randomized, Sequential Design. (NCT03136666) | Bayer | 2010-04-19 |
| Healthy Volunteer Pilot Study Using 3 Types of Modified Release Formulations of Firategrast to Investigate How Quickly Absorption From the Digestive System Takes Place. (NCT01424462) | GlaxoSmithKline | 2010-04-19 |
| Eribulin Mesylate Administered in Combination With Gemcitabine Plus Cisplatin Versus Gemcitabine Plus Cisplatin Alone as First-Line Therapy for Locally Advanced or Metastatic Bladder Cancer (NCT01126749) | Eisai Inc. | 2010-04-16 |
| A Clinical Study Using MEDI-551 in Adult Participants With Relapsed or Refractory Advanced B-Cell Malignancies (NCT00983619) | MedImmune LLC | 2010-04-16 |
| High-Dose Fluconazole for the Treatment of Cryptococcal Meningitis in HIV-Infected Individuals (NCT00885703) | National Institute of Allergy and Infectious Diseases (NIAID) | 2010-04-16 |
| Lenalidomide and Temsirolimus in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma or Non-Hodgkin Lymphoma (NCT01076543) | National Cancer Institute (NCI) | 2010-04-15 |
| AAVRh.10 Administered to Children With Late Infantile Neuronal Ceroid Lipofuscinosis (NCT01414985) | Weill Medical College of Cornell University | 2010-04-15 |
| Study on the Safety of BAY 63-2521, How it is Tolerated and the Way the Body Absorbs, Distributes and Gets Rid of the Study Drug Given as a Single Oral Dose of 1 mg Tablet in Participants With Impaired Liver Function and Healthy Participants Matched for Age-, Gender-, and Weight (NCT04366622) | Bayer | 2010-04-14 |
| Pharmacokinetics and Safety of GSK1325756 in Elderly Subjects and Adult Subjects of in the Fed and Fasted States and in the Presence of a Proton Pump Inhibitors (NCT01209104) | GlaxoSmithKline | 2010-04-14 |
| A Study to Investigate the Interaction of GSK1292263 With Rosuvastatin and Simvastatin in Healthy Subjects (NCT01101568) | GlaxoSmithKline | 2010-04-14 |
| Cediranib Maleate and Olaparib in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Peritoneal Cancer or Recurrent Triple-Negative Breast Cancer (NCT01116648) | National Cancer Institute (NCI) | 2010-04-14 |
| A Pilot Study Using Anakinra/Kineret for the Treatment of Patients With Severe Atopic Dermatitis (NCT01122914) | National Institute of Allergy and Infectious Diseases (NIAID) | 2010-04-14 |
| A Study of LY2875358 in Participants With Advanced Cancer (NCT01287546) | Eli Lilly and Company | 2010-04-13 |
| Study to Assess the Safety of GSK Biologicals' Liquid Human Rotavirus Vaccine in Healthy Infants (NCT01107587) | GlaxoSmithKline | 2010-04-13 |
| Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 139 in Healthy Subjects and Subjects With Moderate to Severe Psoriasis (NCT01094093) | AstraZeneca | 2010-04-11 |
| Gene Therapy for Metachromatic Leukodystrophy (MLD) (NCT01560182) | Orchard Therapeutics | 2010-04-09 |
| Trial to Evaluate the Safety and the Immunogenicity of GSK Biologicals' Influenza Vaccine GSK2186877A in Healthy Children (NCT01096056) | GlaxoSmithKline | 2010-04-05 |
| Intraperitoneal Bortezomib and Carboplatin in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer (NCT01074411) | National Cancer Institute (NCI) | 2010-04-05 |
| A Trial to Determine the Maximum Tolerated Dose and Evaluate the Safety and Pharmacokinetics of Docetaxel-PNP, Polymeric Nanoparticle Formulation of Docetaxel, in Subjects With Advanced Solid Malignancies (NCT01103791) | Samyang Biopharmaceuticals Corporation | 2010-04-01 |
| Single Dose Study of PF-04991532 in Healthy Subjects (NCT01102673) | Pfizer | 2010-04-01 |
| A Study To Evaluate The Safety, Tolerability And Plasma Drug Levels Following A Single Dose Of PF-04995274 In Healthy Adult Volunteers (NCT01091272) | Pfizer | 2010-04-01 |
| A Study to Compare the Effects of Different Sized Particles on Cells in the Nose (NCT01257191) | University of California, Los Angeles | 2010-04-01 |
| A Study to Assess the Systemic Disposition of ASP1585 After Administration of 14C-labeled Drug (NCT01124747) | Astellas Pharma Inc | 2010-04-01 |
| A Study to Evaluate How Tamsulosin (at 1 Dose) and Solifenacin (at 2 Different Doses) Are Taken up From the Intestine, Distributed Through the Body and Eliminated From the Body When Administered in Combination as a Single Tablet (Called EC905) (NCT01953848) | Astellas Pharma Europe B.V. | 2010-04-01 |
| Online Stress Management and Coping Skills Training for Women With Breast Cancer (NCT01335152) | Talaria, Inc | 2010-04-01 |
| Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of YPEG-Filgrastim in Chemotherapy Patients (NCT01238562) | Xiamen Amoytop Biotech Co., Ltd. | 2010-04-01 |
| Storage Lesion in Banked Blood Due to Disruption of Nitric Oxide (NO) Homeostasis (NCT01137656) | Mark Gladwin | 2010-04-01 |
| A Psoriasis Plaque Test Comparing Eight Different Formulations of Vitamin D Analogues for the Treatment of Psoriasis (NCT01105286) | LEO Pharma | 2010-04-01 |
| Immunotherapy With Autologous Tumor Lysate-Loaded Dendritic Cells In Patients With Recurrence Of Glioblastoma Multiforme (NCT04002804) | Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta | 2010-04-01 |
| First In Human Study Of Increasing Oral Doses Of PF-04634817 (NCT01098877) | Pfizer | 2010-04-01 |
| Safety and Efficacy of Belinostat When Used With Standard of Care Chemotherapy for Untreated Non-small Cell Lung Cancer (NCT01090830) | Holy Cross Hospital, Florida | 2010-04-01 |
| Histone Deacetylase Inhibitor LBH589 in Addition to Corticosteroids in Patients With Acute Graft Versus Host Disease (GVHD) (NCT01111526) | H. Lee Moffitt Cancer Center and Research Institute | 2010-04-01 |